Literature DB >> 17140106

[Harmonisation of personal injury compensation in the European Union. Application to medical liability case law].

Jacques Hureau.   

Abstract

Harmonisation of personal injury compensation in the European Union (EU) is crucial. Continuing on from the work begun by the European Federation of Medical Academies, a working party of the XVth Committee of the French National Academy of Medicine has sought to go beyond the restrictive framework of automobile accident compensation in order to address more universal concerns, regardless of the causes and effects of bodily injury. The specific situation of injuries resulting from medical acts was considered, both for its medicolegal complexity and its potential human consequences. After recalling relevant European legislation, the authors consider the different philosophies of medical liability and health care systems in Europe. Methodological convergence is required to achieve harmonisation of personal injury compensation regimes, and especially for the classification of different types of bodily injury, the role of social services, and the establishment of a reference for medical evaluation of injury with built-in compensation levels. The doctrines and concepts of all EU member states (civil law, common law, Nordic medical liability regimes, etc.) are discussed, together with means of facilitating their harmonisation.

Entities:  

Mesh:

Year:  2006        PMID: 17140106

Source DB:  PubMed          Journal:  Bull Acad Natl Med        ISSN: 0001-4079            Impact factor:   0.144


  1 in total

1.  Padova Charter on personal injury and damage under civil-tort law : Medico-legal guidelines on methods of ascertainment and criteria of evaluation.

Authors:  Santo Davide Ferrara; Eric Baccino; Rafael Boscolo-Berto; Giovanni Comandè; Ranieri Domenici; Claudio Hernandez-Cueto; Mete Korkut Gulmen; George Mendelson; Massimo Montisci; Gian Aristide Norelli; Vilma Pinchi; Mohammed Ranavaya; Dina A Shokry; Vera Sterzik; Yvo Vermylen; Duarte Nuno Vieira; Guido Viel; Riccardo Zoja
Journal:  Int J Legal Med       Date:  2015-09-05       Impact factor: 2.686

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.